+ New Watchlist

Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

Bavarian Nordic

BVNRYOTCPK

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$8.72

0.040.46%

At close: -

Bavarian Nordic (BVNRY) Forecast

News

Earnings Bavarian Nordic (BVNRY) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Bavarian Nordic (OTC:BVNRY) Stock

Bavarian Nordic Stock (OTC: BVNRY)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, September 19, 2024

Bavarian Nordic Receives EMA Approval Of Mpox...
Benzinga Newsdesk

Tuesday, September 17, 2024

UK Secures Additional Doses Of Bavarian Nordic Mpox Vaccine To Combat New Variant Threat
Vandana Singh

Friday, September 06, 2024

Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows
Vandana Singh
Mpox Vaccines: Challenges Persist as Congo Receives First Batch Of Doses Almost 2 Years After It Declared Epidemic
Vandana Singh

Monday, August 26, 2024

WHO Seeks $135M In Funding To Fight Mpox: Outbreak 'Can Be Controlled, And Can Be Stopped'
Chris Katje
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain
Vandana Singh

Monday, August 19, 2024

Mpox Variant Sparks Global Concern As Europe, China Ramp Up Screening
Michael Juliano

Friday, August 16, 2024

Mpox Vaccine Maker Bavarian Nordic Targets Broader Access With European Submission For Imvanex Adolescent Use During WHO Emergency
Vandana Singh

Thursday, August 15, 2024

Emergent Biosolutions, Bavarian Nordic, GeoVax And SIGA Technologies Shares Are Making Big Moves Thursday: What's Going On?
Adam Eckert

Wednesday, August 14, 2024

WHO Declares Mpox Public Health Emergency: 'Coordinated International Response Essential' To Halt Outbreak
Chris Katje

Tuesday, June 20, 2023

Bavarian Nordic Beefs Up Chikungunya Vaccine Race With Valneva With Encouraging Late-Stage Trial Data
Vandana Singh

Wednesday, February 15, 2023

Monkeypox Vaccine Maker Bavarian Nordic Bets $380M On Emergent Bio's Travel Vaccines
Vandana Singh

Thursday, December 15, 2022

West Africa-Based Studies Show JNJ, Merck's Ebola Vaccines Provide Lasting Antibodies
Vandana Singh

Thursday, November 03, 2022

Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa
Vandana Singh

Friday, September 02, 2022

White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
Vandana Singh

Friday, August 26, 2022

Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed
Vandana Singh

Thursday, August 25, 2022

SIGA Tech Made The Smallpox Treatment As Post-9/11 Bioterrorism Defense: Report
Vandana Singh

Wednesday, August 24, 2022

Benzinga Before The Bell: Top Amazon Seller Succumbs To Economic Meltdown, Twitter To Tackle Toxic Content, Spam Bots, Bed Bath & Beyond Secures Loan Deal As It Tries To Stay Afloat And Other Top Financial Stories Wednesday, August 24
Akanksha Bakshi
Bavarian Nordic Making All Efforts To Stretch Capacity To Boost Monkeypox Vaccine Supplies
Vandana Singh

Tuesday, August 23, 2022

Experts Cast Doubt On Dependence On Monkeypox Vaccine Amid Limited Trial Data, Supply Crunch
Vandana Singh

Friday, August 19, 2022

Applied DNA Seeks Approval For PCR-Based Monkeypox Virus Test
Vandana Singh
Bavarian Nordic Recruits US Firm For Packaging Services For Its Monkeypox Vaccine
Vandana Singh

Thursday, August 18, 2022

Biden Officials Seek To Boost Supply For Monkeypox Vaccines, Treatment
Vandana Singh

Wednesday, August 17, 2022

The Only Monkeypox Vaccine Maker Finds It Difficult To Meet Accelerating Demand
Vandana Singh

Tuesday, August 09, 2022

FDA Approves New Technique To Extend Supply Of Monkeypox Vaccine: Report
Michael Cohen

Monday, August 01, 2022

Monkeypox Stocks On The Move: What Investors Should Know About The Outbreak
Wayne Duggan

Monday, July 25, 2022

Bavarian Nordic's Monkeypox Vaccine Scores EU Approval As WHO Declares Global Health Emergency
Vandana Singh

Friday, July 22, 2022

Benzinga Before The Bell: Snap's Dismal Earnings, Amazon's Healthcare Foray, Robinhood Moves 41B Dogecoin Into Single Wallet And Other Top Financial Stories Friday, July 22
Akanksha Bakshi
Bavarian Nordic's Monkeypox Vaccine Gets Thumbs Up From EU Regulator
Vandana Singh

Tuesday, July 19, 2022

The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings
Vandana Singh

Monday, July 18, 2022

The Daily Biotech Pulse: Sesen Bio Stops Lead Assest Development In US, FDA Approves Eton Pharma's Partial Seizures Drug, Bavarian Nordic Inks Multiple Supply Pact For Monkeypox Vaccine
Vandana Singh
Bavarian Nordic Inks Multiple Supply Pact For Its Monkey pox Vaccine, Updates FY22 Guidance
Vandana Singh

Thursday, July 14, 2022

Lawmaker Warns San Francisco Faces 'Public Health Mess' Over Monkeypox Vaccine Shortage
Phil Hall

Wednesday, July 13, 2022

Quest Diagnostics Unveils Monkeypox Test: What You Need To Know
Phil Hall

Friday, July 08, 2022

20% Of US Monkeypox Cases Are In This City
Phil Hall

Wednesday, June 29, 2022

White House Outlines New Monkeypox Vaccine Strategy: What You Need To Know
Vandana Singh

Thursday, June 16, 2022

Bavarian Nordic Launches COVID-19 Booster Study To Compare Against Pfizer/BioNTech Shot
Vandana Singh

Tuesday, June 14, 2022

Morning Brief: Top Financial Stories Dominating on Tuesday, June 14
Akanksha Bakshi
EU, Bavarian Nordic Ink Supply Pact For 110,000 Monkeypox Vaccines
Vandana Singh

Tuesday, May 24, 2022

This Famed Company Is Working On A Potential Monkeypox Vaccine
Vandana Singh

Friday, May 20, 2022

Analysis: Should You Be Afraid Of A Monkeypox Pandemic?
Phil Hall

Monday, December 09, 2019

Vaccine Regimen from Janssen and Bavarian Nordic to Support Republic of Rwanda's Preparedness Against Ebola Outbreak
Charles Gross

Monday, October 21, 2019

Bavarian Nordic Announces Acquisition of Two Established Commercial Vaccines from GlaxoSmithKline for ~€796M
Charles Gross

Thursday, November 09, 2017

Bavarian Nordic Initiates Phase 2 Booster Study of its Universal RSV Vaccine
Benzinga

Monday, August 03, 2015

Kerrisdale Capital Announces Latest Short Position, Bavarian Nordic
Benzinga
Kerrisdale Capital Announces Bavarian Nordic ...
Benzinga

Tuesday, May 12, 2015

Bavarian Nordic Announces Presentation of Preliminary Phase 1 Results for Ebola Prime-Boost Vaccine Regimen of MVA-BN Filo and Janssen's AdVac
Benzinga

Wednesday, March 04, 2015

Bristol-Myers Squibb to Pay Bavarian Nordic Up to $975M for PROSTVAC License
Benzinga

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved